Literature DB >> 7822570

Fear of physical sensations and trait anxiety as mediators of the response to hyperventilation in nonclinical subjects.

R M Rapee1, L Medoro.   

Abstract

Three studies were conducted to compare the ability of a measure of fear of physical sensations (Anxiety Sensitivity Index; ASI) and a measure of trait anxiety (State-Trait Anxiety Inventory; STAI) to predict response to hyperventilation. In the first study subjects (N = 43) were selected who differed in scores on the ASI but were equated on levels of trait anxiety. Two other studies were conducted in which subjects (ns = 63 and 54) varied randomly on ASI and STAI scores. The results indicate that scores on the ASI account for a significant proportion of variance in the response to hyperventilation that is not accounted for by scores on the STAI.

Entities:  

Mesh:

Year:  1994        PMID: 7822570     DOI: 10.1037//0021-843x.103.4.693

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  42 in total

1.  The role of anxiety sensitivity in the relation between trait worry and smoking behavior.

Authors:  Hyaneyoung Olvera; Jafar Bakhshaie; Lorra Garey; Charles Jardin; Norman B Schmidt; Michael J Zvolensky
Journal:  Nicotine Tob Res       Date:  2014-11-03       Impact factor: 4.244

Review 2.  Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity.

Authors:  Adam M Leventhal; Michael J Zvolensky
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

3.  Negative affect as a mediator of the relationship between vigorous-intensity exercise and smoking.

Authors:  Candyce D Tart; Teresa M Leyro; Ashley Richter; Michael J Zvolensky; David Rosenfield; Jasper A J Smits
Journal:  Addict Behav       Date:  2010-02-01       Impact factor: 3.913

4.  Incremental validity of anxiety sensitivity in relation to marijuana withdrawal symptoms.

Authors:  Marcel O Bonn-Miller; Michael J Zvolensky; Erin C Marshall; Amit Bernstein
Journal:  Addict Behav       Date:  2006-12-19       Impact factor: 3.913

5.  An integrated approach to panic prevention targeting the empirically supported risk factors of smoking and anxiety sensitivity: theoretical basis and evidence from a pilot project evaluating feasibility and short-term efficacy.

Authors:  Matthew T Feldner; Michael J Zvolensky; Kimberly Babson; Ellen W Leen-Feldner; Norman B Schmidt
Journal:  J Anxiety Disord       Date:  2008-01-11

6.  Relations between anxiety sensitivity, distress tolerance, and fear reactivity to bodily sensations to coping and conformity marijuana use motives among young adult marijuana users.

Authors:  Michael J Zvolensky; Erin C Marshall; Kirsten Johnson; Julianna Hogan; Amit Bernstein; Marcel O Bonn-Miller
Journal:  Exp Clin Psychopharmacol       Date:  2009-02       Impact factor: 3.157

7.  Linkages between cigarette smoking outcome expectancies and negative emotional vulnerability.

Authors:  Kirsten A Johnson; Michael J Zvolensky; Erin C Marshall; Adam Gonzalez; Kenneth Abrams; Anka A Vujanovic
Journal:  Addict Behav       Date:  2008-05-14       Impact factor: 3.913

8.  An evaluation of anxiety sensitivity, emotional dysregulation, and negative affectivity among daily cigarette smokers: relation to smoking motives and barriers to quitting.

Authors:  Adam Gonzalez; Michael J Zvolensky; Anka A Vujanovic; Teresa M Leyro; Erin C Marshall
Journal:  J Psychiatr Res       Date:  2008-04-15       Impact factor: 4.791

9.  The Moderating Effect of Smoking Status on the Relation between Anxiety Sensitivity, Sexual Compulsivity, and Suicidality among People with HIV/AIDS.

Authors:  Charles Philip Brandt; Jafar Bakhshaie; Charles Jardin; Chad Lemaire; Brooke Y Kauffman; Carla Sharp; Michael J Zvolensky
Journal:  Int J Behav Med       Date:  2017-02

Review 10.  Interoception in Psychiatric Disorders: A Review of Randomized, Controlled Trials with Interoception-Based Interventions.

Authors:  Nayla M Khoury; Jacqueline Lutz; Zev Schuman-Olivier
Journal:  Harv Rev Psychiatry       Date:  2018 Sep/Oct       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.